Hedi Raizer
Journal
853 articles
- NAD+: mechanism of action Nicotinamide adenine dinucleotide (NAD+) is a redox coenzyme and substrate for sirtuins, PARPs and CD38. This...
- PEG-MGF: Mechanism of Action PEG-MGF is a pegylated synthetic analogue of mechano growth factor (MGF), the IGF-1Ec splice variant of the IG...
- Cerebrolysin: mechanism of action Cerebrolysin is a multimodal neuropeptide preparation studied for its effects on neuroprotection, neuroplastic...
- BPC-157: mechanism of action BPC-157 is a synthetic pentadecapeptide studied for cytoprotective and regenerative activity. This page summar...
- Hexarelin: mechanism of action Hexarelin is a synthetic growth hormone secretagogue peptide that acts at the GHS-R1a receptor. This page revi...
- Cagrilintide: mechanism of action Cagrilintide is a long-acting amylin receptor agonist. This page sets out its receptor pharmacology, the brain...
- GHK-Cu: mechanism of action GHK-Cu is a copper(II) tripeptide complex studied for its catalytic, antioxidant and signalling activity. This...
- Melanotan II: mechanism of action Melanotan II is a synthetic cyclic melanocortin peptide that acts primarily through melanocortin 1 receptor ac...
- GHRP-6: Mechanism of Action GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that acts through the ghrelin receptor (GHSR-1a)...
- Tirzepatide: mechanism of action Tirzepatide is a dual GIP and GLP-1 receptor agonist. This page summarises its mechanism of action and the res...
- Sermorelin: mechanism of action Sermorelin is a GHRH analogue that acts on pituitary GHRH receptors to stimulate endogenous growth hormone rel...
- CJC-1295 with DAC: mechanism of action CJC-1295 with DAC is a GHRH analogue bearing a Drug Affinity Complex that extends its plasma residence time; t...
- Retatrutide: mechanism of action Retatrutide (LY3437943) is an investigational triple agonist at the GIP, GLP-1 and glucagon receptors. This pa...
- PEG-MGF: what the published research shows A research-use-only review of PEG-MGF (pegylated mechano growth factor), covering its formal nomenclature, the...
- ARA-290: what the published research shows ARA-290 is a non-hematopoietic erythropoietin analogue studied in diabetic macular oedema, sarcoidosis small f...
- BPC-157: what the published research shows A research summary of BPC-157 (body protection compound 157), a synthetic pentadecapeptide studied in preclini...
- Semaglutide: what the published research shows A research-focused summary of published and registered studies on semaglutide, covering its receptor target, t...
- Thymosin Alpha-1: what the published research shows A research summary of published preclinical and clinical literature on Thymosin Alpha-1 (Tα1), covering its re...